Shuttle Pharmaceuticals Holdings, Inc. SHPH
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 15.14% | 29.50% | -63.58% | 37.97% | -82.48% |
| Total Depreciation and Amortization | 126,680.00% | 0.00% | 15,961.11% | 25.00% | -200.00% |
| Total Amortization of Deferred Charges | -2,802.14% | 9,815.38% | -- | -92.64% | -93.95% |
| Total Other Non-Cash Items | 122.10% | -106.92% | 615.45% | -68.94% | -202.41% |
| Change in Net Operating Assets | 253.47% | -1,024.32% | 158.31% | -147.03% | 1,203.64% |
| Cash from Operations | 83.08% | 4.34% | 63.83% | -31.43% | -139.77% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | 81.08% | 87.36% |
| Issuance of Common Stock | -- | -38.94% | -43.29% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 608.32% | 47.20% | 101.59% | 69.32% | -235.25% |
| Cash from Financing | 36.62% | -37.31% | -49.05% | 51.02% | 892.74% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -427.66% | -70.84% | -199.84% | -405.29% | 143.40% |